Wnt2 acts as a cell type–specific, autocrine growth factor in rat hepatic sinusoidal endothelial cells cross-stimulating the VEGF pathway

Authors

  • Diana Klein,

    Corresponding author
    1. Department of Dermatology, Venereology, and Allergology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany
    • Department of Dermatology, Venereology, and Allergology, University Medical Center Mannheim, Ruprecht-Karl University Heidelberg, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany
    Search for more papers by this author
    • fax: (49) 0621-383-3815

  • Alexandra Demory,

    1. Department of Dermatology, Venereology, and Allergology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany
    Search for more papers by this author
  • Francis Peyre,

    1. Department of Dermatology, Venereology, and Allergology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany
    Search for more papers by this author
  • Jens Kroll,

    1. Joint Research Division of Vascular Biology, Medical Faculty Mannheim, University of Heidelberg, and German Cancer Research Center Heidelberg, Germany
    Search for more papers by this author
  • Hellmut G. Augustin,

    1. Joint Research Division of Vascular Biology, Medical Faculty Mannheim, University of Heidelberg, and German Cancer Research Center Heidelberg, Germany
    Search for more papers by this author
  • Wijnand Helfrich,

    1. Department of Medical Biology, University Medical Center, University of Groningen, Groningen, The Netherlands
    Search for more papers by this author
  • Julia Kzhyshkowska,

    1. Department of Dermatology, Venereology, and Allergology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany
    Search for more papers by this author
  • Kai Schledzewski,

    1. Department of Dermatology, Venereology, and Allergology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany
    Search for more papers by this author
  • Bernd Arnold,

    1. Department of Molecular Immunology, University of Heidelberg, and German Cancer Research Center Heidelberg, Germany
    Search for more papers by this author
  • Sergij Goerdt

    1. Department of Dermatology, Venereology, and Allergology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany
    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

Abstract

The mechanisms regulating the growth and differentiation of hepatic sinusoidal endothelial cells (HSECs) are not well defined. Because Wnt signaling has become increasingly important in developmental processes such as vascular and hepatic differentiation, we analyzed HSEC-specific Wnt signaling in detail. Using highly pure HSECs isolated by a newly developed protocol selecting against nonsinusoidal hepatic endothelial cells, we comparatively screened the multiple components of the Wnt pathway for differential expression in HSECs and lung microvascular endothelial cells (LMECs) via reverse-transcription polymerase chain reaction (RT-PCR). As confirmed via quantitative RT-PCR and northern and western blotting experiments, Wnt2 (and less so Wnt transporter wls/evi) and Wnt coreceptor Ryk were overexpressed by HSECs, whereas Wnt inhibitory factor (WIF) was strongly overexpressed by LMECs. Exogenous Wnt2 superinduced proliferation of HSECs (P < 0.05). The Wnt inhibitor secreted frizzled-related protein 1 (sFRP1) (P < 0.005) and transfection of HSECs with Wnt2 small interfering RNA (siRNA) reduced proliferation of HSECs. These effects were rescued by exogenous Wnt2. Tube formation of HSECs on matrigel was strongly inhibited by Wnt inhibitors sFRP1 and WIF (P < 0.0005). Wnt signaling in HSECs activated the canonical pathway inducing nuclear translocation of β-catenin. GST (glutathione transferase) pull-down and co-immunoprecipitation assays showed Fzd4 to be a novel Wnt2 receptor in HSECs. Gene profiling identified vascular endothelial growth factor receptor-2 (VEGFR-2) as a target of Wnt2 signaling in HSECs. Inhibition of Wnt signaling down-regulated VEGFR-2 messenger RNA and protein. Wnt2 siRNA knock-down confirmed Wnt2 specificity of VEGFR-2 regulation in HSECs. Conclusion: Wnt2 is an autocrine growth and differentiation factor specific for HSECs that synergizes with the VEGF signaling pathway to exert its effects. (HEPATOLOGY 2008;47:1018–1031.)

Ancillary